Collectively, these results suggest a complex regulatory network in which FTH1 influences pancreatic cancer progression by modulating PYCR1 expression, which in turn may be part of a feedback loop involving proline that controls the effects of FTH1, thus impacting cell viability and proliferation. The gene discussed is FTH1; the disease is pancreatic neoplasm.